Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

23.11 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
From Fulgent Genetics, Inc.
Via Business Wire
NASDAQ:FLGT Long Term Investor Alert: Investigation of Potential Wrongdoing at Fulgent Genetics, Inc.
San Diego, CA -- (SBWIRE) -- 02/09/2023 -- An investigation was announced for current long-term investors in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) concerning potential breaches of fiduciary... 
Via SBWire
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Where Fulgent Genetics Stands With Analysts
 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's trading, 71 companies set new 52-week lows. 
Via Benzinga
Fulgent Expands Board of Directors with Addition of Reggie Groves
From Fulgent Genetics, Inc.
Via Business Wire
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
Fulgent Genetics's Return on Invested Capital Insights
 
Via Benzinga
1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings
Strong core business growth was overshadowed in Q3 by an acquisition. 
Via The Motley Fool
4 Analysts Have This to Say About Fulgent Genetics
 
Via Benzinga
Which Is the Better Buy: Vertex or Invitae?
Is Vertex worth its lofty valuation compared to Invitae? 
Via The Motley Fool
My Top 7 Strong Conviction Buys for 2023
Companies that are down on their luck this year are in strong contention for conviction buys for 2023 as they rebound. 
Via InvestorPlace
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
FLGT FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
From The Law Offices of Frank R. Cruz
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Upgrades 
Via Benzinga
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
FLGT DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
NASDAQ:FLGT Investor Alert: Deadline on November 21, 2022 in Lawsuit Against Fulgent Genetics, Inc.
San Diego, CA -- (SBWIRE) -- 11/15/2022 -- The Shareholders Foundation announced that a deadline is coming up on November 21, 2022 in the lawsuit filed for certain investors of Fulgent Genetics, Inc.... 
Via SBWire
Deadline Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Class Action Deadlines and Encourages Shareholders to Contact the Firm and Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Fulgent Genetics, Inc.
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics Reports Third Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.